UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

565 Preclinical evaluation of OTX015, a novel BET-BRD inhibitor, on small cell lung cancer (SCLC) cell lines

European journal of cancer (1990), 2014-11, Vol.50, p.183-183

2014

Volltextzugriff (PDF)

469 OTX015, a novel BET-bromodomain (BET-BRD) inhibitor, is a promising anticancer agent for human glioblastoma

European journal of cancer (1990), 2014-11, Vol.50, p.153-153

2014

Volltextzugriff (PDF)

587 Cellular pharmacokinetics and molecular pharmacodynamics studies of the BRD-BET inhibitor OTX015 in sensitive and resistant leukemic cell lines

European journal of cancer (1990), 2014-11, Vol.50, p.189-189

2014

Volltextzugriff (PDF)

Il rifornimento dell’esercito napoletano tra ‘700 e ‘800: Giacinto Cafiero asientista generale de viveri e foraggi

Revista historia autónoma, 2021 (19), p.147-168

Odore, Angelo

2021

Volltextzugriff (PDF)

OTX015 (MK‐8628), a novel BET inhibitor, displays in vitro and in vivo antitumor effects alone and in combination with conventional therapies in glioblastoma models

International journal of cancer, 2016-11, Vol.139 (9), p.2047-2055

2016

Volltextzugriff (PDF)

Phase I Population Pharmacokinetic Assessment of the Oral Bromodomain Inhibitor OTX015 in Patients with Haematologic Malignancies

Clinical pharmacokinetics, 2016-03, Vol.55 (3), p.397-405

2016

Volltextzugriff (PDF)

Ripensare la Rivoluzione francese a Marsiglia attraverso il GIS. Il caso delle pattuglie borghesi nel 1789

Il Risorgimento, 2021 (2), p.7-50

2021

Volltextzugriff (PDF)

The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus

Oncotarget, 2017-01, Vol.8 (5), p.7598-7613

2017

Volltextzugriff (PDF)

OTX015 (MK-8628), a novel BET inhibitor, exhibits antitumor activity in non-small cell and small cell lung cancer models harboring different oncogenic mutations

Oncotarget, 2016-12, Vol.7 (51), p.84675-84687

2016

Volltextzugriff (PDF)

A study to compare circulating flunixin, meloxicam and gabapentin concentrations with prostaglandin E2 levels in calves undergoing dehorning

Research in veterinary science, 2013-08, Vol.95 (1), p.204-211

2013

Volltextzugriff (PDF)

Canine leishmaniosis: in vitro efficacy of miltefosine and marbofloxacin alone or in combination with allopurinol against clinical strains of Leishmania infantum

Parasitology research (1987), 2012-06, Vol.110 (6), p.2509-2513

2012

Volltextzugriff (PDF)

Seasonality of reproduction in wild boar (Sus scrofa) assessed by fecal and plasmatic steroids

Theriogenology, 2010-06, Vol.73 (9), p.1230-1237

2010

Volltextzugriff (PDF)

Effects of competition on acute phase proteins and lymphocyte subpopulations – oxidative stress markers in eventing horses

Journal of animal physiology and animal nutrition, 2015-10, Vol.99 (5), p.856-863

2015

Volltextzugriff (PDF)

Insights into the cellular pharmacological properties of the BET-inhibitor OTX015/MK-8628 (birabresib), alone and in combination, in leukemia models

Leukemia & lymphoma, 2019-10, Vol.60 (12), p.3067-3070

2019

Volltextzugriff (PDF)

Abstract 3527: OTX015, a novel BET-bromodomain (BET-BRD) inhibitor, displays antitumoral effects in orthotopic and heterotopic models of human glioblastoma

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.3527-3527

2015

Volltextzugriff (PDF)

OTX015 (MK-8628), a novel BET inhibitor, displays in vitroand in vivo antitumor effects alone and in combination withconventional therapies in glioblastoma models

International journal of cancer, 2016, Vol.139 (9), p.2047-2055

2016

Volltextzugriff (PDF)

Physiopathological changes related to the use of ractopamine in swine: Clinical and pathological investigations

Livestock science, 2012-03, Vol.144 (1-2), p.74-81

2012

Volltextzugriff (PDF)

Abstract CT231: BET-bromodomain inhibitor OTX015 shows clinically meaningful activity at nontoxic doses: interim results of an ongoing phase I trial in hematologic malignancies

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.CT231-CT231

2014

Volltextzugriff (PDF)

Estimation of the workload in horses during an eventing competition

Comparative exercise physiology, 2013-01, Vol.9 (2), p.93-101

2013

Volltextzugriff (PDF)

Effects of brief maternal separation in kids on neurohormonal and electroencephalographic parameters

Applied animal behaviour science, 2005-09, Vol.93 (1), p.39-52

2005

Volltextzugriff (PDF)

Changes in lymphocyte glucocorticoid and β-adrenergic receptors in veal calves treated with clenbuterol and steroid hormones for growth-promoting purposes

Journal of veterinary pharmacology and therapeutics, 2006-04, Vol.29 (2), p.91-97

2006

Volltextzugriff (PDF)

Steroid and 3-adrenergic receptor modifications in target organs of broiler chickens fed with a diet containing β2-adrenergic agents

Food and chemical toxicology, 2008, Vol.46 (6), p.2239-2243

2008

Volltextzugriff (PDF)

Electroencephalographic power spectral analysis of growing goat kids ( Capra hircus)

Small ruminant research, 2006-11, Vol.66 (1), p.265-272

2006

Volltextzugriff (PDF)

Mepartricin long-term administration regulates steroid hormone and adrenergic receptor concentrations in the prostate of aged rats

Journal of veterinary pharmacology and therapeutics, 2006-08, Vol.29 (4), p.289-297

2006

Volltextzugriff (PDF)

A02Effects of housing and short term transportation on hormonal levels and on lymphocyte glucocorticoid and β-adrenergic receptor concentrations in beef calves

Journal of veterinary pharmacology and therapeutics, 2006-10, Vol.29 (s1), p.52-53

2006

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(37)

Sprache

Englisch
(35)
Italienisch
(2)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

565 Preclinical evaluation of OTX015, a novel BET-BRD inhibitor, on small cell lung cancer (SCLC) cell lines

469 OTX015, a novel BET-bromodomain (BET-BRD) inhibitor, is a promising anticancer agent for human glioblastoma

587 Cellular pharmacokinetics and molecular pharmacodynamics studies of the BRD-BET inhibitor OTX015 in sensitive and resistant leukemic cell lines

Il rifornimento dell’esercito napoletano tra ‘700 e ‘800: Giacinto Cafiero asientista generale de viveri e foraggi

OTX015 (MK‐8628), a novel BET inhibitor, displays in vitro and in vivo antitumor effects alone and in combination with conventional therapies in glioblastoma models

Phase I Population Pharmacokinetic Assessment of the Oral Bromodomain Inhibitor OTX015 in Patients with Haematologic Malignancies

Ripensare la Rivoluzione francese a Marsiglia attraverso il GIS. Il caso delle pattuglie borghesi nel 1789

The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus

OTX015 (MK-8628), a novel BET inhibitor, exhibits antitumor activity in non-small cell and small cell lung cancer models harboring different oncogenic mutations

A study to compare circulating flunixin, meloxicam and gabapentin concentrations with prostaglandin E2 levels in calves undergoing dehorning

Canine leishmaniosis: in vitro efficacy of miltefosine and marbofloxacin alone or in combination with allopurinol against clinical strains of Leishmania infantum

Seasonality of reproduction in wild boar (Sus scrofa) assessed by fecal and plasmatic steroids

Effects of competition on acute phase proteins and lymphocyte subpopulations – oxidative stress markers in eventing horses

Insights into the cellular pharmacological properties of the BET-inhibitor OTX015/MK-8628 (birabresib), alone and in combination, in leukemia models

Abstract 3527: OTX015, a novel BET-bromodomain (BET-BRD) inhibitor, displays antitumoral effects in orthotopic and heterotopic models of human glioblastoma

OTX015 (MK-8628), a novel BET inhibitor, displays in vitroand in vivo antitumor effects alone and in combination withconventional therapies in glioblastoma models

Physiopathological changes related to the use of ractopamine in swine: Clinical and pathological investigations

Abstract CT231: BET-bromodomain inhibitor OTX015 shows clinically meaningful activity at nontoxic doses: interim results of an ongoing phase I trial in hematologic malignancies

Estimation of the workload in horses during an eventing competition

Effects of brief maternal separation in kids on neurohormonal and electroencephalographic parameters

Changes in lymphocyte glucocorticoid and β-adrenergic receptors in veal calves treated with clenbuterol and steroid hormones for growth-promoting purposes

Steroid and 3-adrenergic receptor modifications in target organs of broiler chickens fed with a diet containing β2-adrenergic agents

Electroencephalographic power spectral analysis of growing goat kids ( Capra hircus)

Mepartricin long-term administration regulates steroid hormone and adrenergic receptor concentrations in the prostate of aged rats

A02Effects of housing and short term transportation on hormonal levels and on lymphocyte glucocorticoid and β-adrenergic receptor concentrations in beef calves

Suchergebnisse filtern